SolasCure Ltd
SolasCure is a pioneering biologics company committed to addressing the pressing issue of inadequate debridement and healing solutions for chronic wounds. Our product, Aurase Wound Gel addresses a significant unmet medical need - better wound bed preparation is a growing and urgent problem without safe and effective solutions. This innovative approach incorporates biomimicry of medical maggots' natural processes that clean wounds and promote healing. We aim to provide accessible solutions across all settings from hospital to home care. SolasCure was founded in 2017 as a spin-off from BRAIN Biotech AG, a leading German biotech company focused on harnessing biological diversity to develop innovative solutions.Content by SolasCure Ltd
| 2 min read
Peer-reviewed study in the International Wound Journal indicates that Aurase Wound Gel can achieve debridement without any additional pain to the patient
| 2 min read
Fast Track is designed to facilitate development and expedite review of drugs to treat significant unmet medical need, fostering closer collaboration with the FDA
Page 1 of 1 - 2 Total Items
